Publication
The action of acetyl-L-carnitine in dopaminergic neurotransmission
| dc.contributor.author | Cunha, Lídia | |
| dc.contributor.author | Szigeti, Krisztian | |
| dc.contributor.author | Mathe, Domokos | |
| dc.contributor.author | Metello, Luis | |
| dc.date.accessioned | 2019-11-26T13:08:15Z | |
| dc.date.available | 2019-11-26T13:08:15Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Acetyl-L-Carnitine (ALC) has been described as playing a neuroprotective effect against a variety of substances. However, the molecular mechanisms underlying its action, particularly regarding the induction of changes in neurotransmitter system, are still not fully understood. Using both a cell line and an animal model of exposure to methamphetamine (METH), we aim to contribute to clarify the mechanism by which the administration of ALC alters neurotransmitter release. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.22/14948 | |
| dc.language.iso | eng | pt_PT |
| dc.relation.publisherversion | http://jnm.snmjournals.org/content/55/supplement_1/1807.short | pt_PT |
| dc.subject | acetyl-L-carnitine | pt_PT |
| dc.subject | dopaminergic | pt_PT |
| dc.title | The action of acetyl-L-carnitine in dopaminergic neurotransmission | pt_PT |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | Suppl 1 | pt_PT |
| oaire.citation.title | Journal of Nuclear Medicine | pt_PT |
| oaire.citation.volume | 55 | pt_PT |
| person.familyName | Cunha | |
| person.givenName | Lídia | |
| person.identifier.orcid | 0000-0002-9260-8093 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | conferenceObject | pt_PT |
| relation.isAuthorOfPublication | ed51e8c5-a1c2-40e6-b976-57af77446e1b | |
| relation.isAuthorOfPublication.latestForDiscovery | ed51e8c5-a1c2-40e6-b976-57af77446e1b |